Company Filing History:
Years Active: 2019-2025
Title: Innovations in Eye Treatment by Inventor Alexandra Nicklin
Introduction
Alexandra Nicklin is a prominent inventor based in Cambridge, MA (US), known for her significant contributions to eye treatment technologies. With a total of 4 patents to her name, she has been at the forefront of developing innovative solutions for corneal treatments.
Latest Patents
Among her latest patents, one notable invention is titled "Systems and methods for cross-linking treatments of an eye." This patent describes a method for determining an area at the surface of the cornea for the delivery of a cross-linking agent. The treatments aim to disrupt tissue at the cornea's surface to a depth of approximately 10 μm to 15 μm. The cross-linking agent is applied to the disrupted area, allowing for enhanced transmission through the cornea. Additionally, the invention includes the delivery of photoactivating light to activate the cross-linking agent, generating cross-linking activity within the cornea.
Another significant patent is focused on "Formulations for eye treatments." This patent outlines therapeutic formulations that include a photosensitizer and various delivery agents, such as anesthetic and analgesic agents. The methods described in this patent aim to increase the permeability of the corneal epithelium, facilitating the delivery of therapeutic formulations to the stroma.
Career Highlights
Alexandra Nicklin is currently associated with Avedro, Inc., where she continues to innovate in the field of ophthalmology. Her work has been instrumental in advancing treatments that improve patient outcomes in eye care.
Collaborations
Throughout her career, Alexandra has collaborated with notable professionals in her field, including Marc David Friedman and Pavel Kamaev. These collaborations have further enhanced her research and development efforts.
Conclusion
Alexandra Nicklin's innovative work in eye treatment technologies showcases her dedication to improving healthcare solutions. Her patents reflect a commitment to advancing the field of ophthalmology and enhancing the quality of life for patients.